Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): Current literature review

Journal of Thoracic Disease

Volumn 6, Issue SUPPL1, 2014, Pages

  Papaiwannou, Antonis ^a   Zarogoulidis, Paul ^a   Porpodis, Konstantinos ^a   Spyratos, Dionysios ^a   Kioumis, Ioannis ^a   Pitsiou, Georgia ^a   Pataka, Athanasia ^a   Tsakiridis, Kosmas ^b   Arikas, Stamatis ^b   Mpakas, Andreas ^b   Tsiouda, Theodora ^c   Katsikogiannis, Nikolaos ^d   Kougioumtzi, Ioanna ^d   Machairiotis, Nikolaos ^d   Siminelakis, Stavros ^e   Kolettas, Alexander ^b   Kessis, George ^b   Beleveslis, Thomas ^b   Zarogoulidis, Konstantinos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Cardiothoracic Surgery Department 'Saint Luke' Private Hospital   (Greece)

^c UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

^d Internal Medicine Department 'Theageneio' Cancer Hospital   (Greece)

^e UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Asthma; Chronic obstructive pulmonary disease (COPD); Overlap

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN E; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SURFACTANT PROTEIN A;

AGE DISTRIBUTION; AIRWAY OBSTRUCTION; AIRWAY REMODELING; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; HUMAN; MORTALITY; NEUTROPHIL; PATHOGENESIS; PHENOTYPE; PREVALENCE; PROTEIN EXPRESSION; QUALITY OF LIFE; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SPUTUM; SYMPTOMATOLOGY;

EID: 84900399727     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.03.04     Document Type: Review

References (61)

1. American Thoracic Society. Standards for diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-121.
2. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003;124:474-81.
3. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Aten Primaria 2012;44:425-37.
4. Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012;48:331-7.
5. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
6. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008;31:742-50.
7. Zeki AA, Schivo M, Chan A, et al. The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly. J Allergy (Cairo) 2011;2011:861926.
8. Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol 2013;6:197-219.
9. National Heart, Lung, and Blood Institutes. Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung and Blood Diseases. National Institutes of Health, MD, USA, 2009.
10. Schiller JS, Lucas JW, Ward BW, et al. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat 10 2012:1-207.
11. Center for Disease Control. Asthma in the U.S. Vital Signs, 2011.
12. Miniño AM, Murphy SL, Xu J, et al. Deaths: final data for 2008. Natl Vital Stat Rep 2011;59:1-126.
13. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One 2013;8:e62985.
14. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Bethesda, MD: U.S. Department of Health and Human Services, of Health, National National Institutes Heart, Lung, and Blood Institute, 2007.
15. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO Workshop Report. Updated 2011.
16. Douwes J, Gibson P, Pekkanen J, et al. Noneosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643-8.
17. Cowan DC, Cowan JO, Palmay R, et al. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65:384-90.
18. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-30.
19. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168:1308-11.
20. Chanez P, Vignola AM, O'Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997;155:1529-34.
21. Boulet LP, Turcotte H, Turcot O, et al. Airway inflammation in asthma with incomplete reversibility of airflow obstruction. Respir Med 2003;97:739-44.
22. Shaw DE, Berry MA, Hargadon B, et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 2007;132:1871-5.
23. Jang AS, Lee JH, Park SW, et al. Risk factors related to fixed airway obstruction in patients with asthma after antiasthma treatment. Ann Allergy Asthma Immunol 2007;99:408-12.
24. Hamid Q, Tulic MK. New insights into the pathophysiology of the small airways in asthma. Ann Thorac Med 2007;2:28-33.
25. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
26. Kitaguchi Y, Komatsu Y, Fujimoto K, et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis 2012;7: 283-9.
27. Bumbacea D, Campbell D, Nguyen L, et al. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004;24:122-8.
28. Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000;55:198-204.
29. Park JW, Hong YK, Kim CW, et al. High resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary function and bronchial hyperresponsiveness. J Investig Allergol Clin Immunol 1997;7:186-92.
30. Bosken CH, Wiggs BR, Pare PD, et al. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis 1990;142:563-70.
31. Nagai A, West WW, Thurlbeck WM, et al. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial: pathology studies. II. Correlation between morphologic findings, clinical findings and evidence of expiratory airflow obstruction. Am Rev Respir Dis 1985;132:946-53.
32. Wright JL, Lawson LM, Pare PD, et al. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983;127:474-7.
33. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary function tests. N Engl J Med 1978;298:1277-81.
34. Sköld CM. Remodeling in asthma and COPD--differences and similarities. Clin Respir J 2010;4 Suppl 1:20-7.
35. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39:131-6.
36. Backman KS, Greenberger PA, Patterson R. Airways obstruction in patients with long-term asthma consistent with irreversible asthma. Chest 1997;112:1234-40.
37. Panizza JA, James AL, Ryan G, et al. Mortality and airflow obstruction in asthma: a 17-year follow-up study. Intern Med J 2006;36:773-80.
38. Vonk JM, Jongepier H, Panhuysen CIM, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58:322-7.
39. Postma DS, Kerstjens HAM. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:S187-92.
40. Scichilone N, Battaglia S, La Sala A, et al. Clinical implications of airway hyper-responsiveness in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:49-60.
41. Vestbo J, Hansen EF. Airway hyperresponsiveness and COPD mortality. Thorax 2001;56: ii11-4.
42. Postma DS, Kerstjens HAM. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:S187-92.
43. Vestbo J, Prescott E. Update on the "Dutch hypothesis" for chronic respiratory disease. Thorax 1998;53:S15-9.
44. Xu X, Rijcken B, Schouten JP, et al. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997;350:1431-4.
45. Brutsche MH, Downs SH, Schindler C, et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006;61:671-7.
46. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-35.
47. Rijcken B, Schouten JP, Mensinga TT, et al. Factors associated with bronchial responsiveness to histamine in a population sample of adults. Am Rev Respir Dis 1993;147:1447-53.
48. Chinn S, Jarvis D, Luczynska CM, et al. An increase in bronchial responsiveness is associated with continuing or restarting smoking. Am J Respir Crit Care Med 2005;172:956-61.
49. Scichilone N, Battaglia S, La Sala A, et al. Clinical implications of airway hyper-responsiveness in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:49-60.
50. Hardin M, Silverman EK, Barr RG, et al. COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127.
51. Soriano JB, Visick GT, Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128:2099-107.
52. National Institutes of Health-National Asthma Education and Prevention Program. Expert Panel 3. Guidelines for the diagnosis and management of asthma-Full Report 2007.
53. Menezes AM, de Oca MM, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014;145:297-304.
54. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med 2007;158:700-5.
55. Orie NG. The dutch hypothesis. Chest 2000;117:299S.
56. Burrows B, Knudson RJ, Lebowitz MD. The relationship of childhood respiratory illness to adult obstructive airway disease. Am Rev Respir Dis 1977;115:751-60.
57. Stick S. The contribution of airway development to paediatric and adult lung disease. Thorax 2000;55: 587-94.
58. Iwamoto H, Gao J, Koskela J, et al. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir J 2014;43:421-9.
59. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011;48:279-85.
60. Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med 2013;107:1053-60.
61. Andersén H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J 2013;7:342-6.